Details of the Drug Combinations

General Information of This Drug (ID: DMSG91J)

Drug Name
ER819762   DMSG91J
Synonyms ER-819762; ER 819762
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

516 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
10-hydroxycamptothecin + ER819762 DC6XWVV 10-hydroxycamptothecin Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
ABIRATERONE + ER819762 DC8YYWX ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [3]
ABIRATERONE + ER819762 DCLO1KI ABIRATERONE Large cell lung carcinoma (Cell Line: NCI-H460) [2]
ABIRATERONE + ER819762 DCBILKQ ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [2]
ABIRATERONE + ER819762 DCX1AZ6 ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [2]
Altretamine + ER819762 DCJXSFT Altretamine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Altretamine + ER819762 DCN6RIP Altretamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Altretamine + ER819762 DCJUH1G Altretamine Carcinoma (Cell Line: MCF7) [4]
Aminolevulinic Acid Hydrochloride + ER819762 DC4YMKM Aminolevulinic Acid Hydrochloride Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Aminolevulinic Acid Hydrochloride + ER819762 DC6R5BP Aminolevulinic Acid Hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Aminolevulinic Acid Hydrochloride + ER819762 DC44JHR Aminolevulinic Acid Hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Aminolevulinic Acid Hydrochloride + ER819762 DC83HYH Aminolevulinic Acid Hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Aminolevulinic Acid Hydrochloride + ER819762 DC2OF28 Aminolevulinic Acid Hydrochloride Lung adenocarcinoma (Cell Line: HOP-62) [2]
Aminolevulinic Acid Hydrochloride + ER819762 DCXWDTV Aminolevulinic Acid Hydrochloride Lung adenocarcinoma (Cell Line: EKVX) [2]
Aminolevulinic Acid Hydrochloride + ER819762 DCMYTTK Aminolevulinic Acid Hydrochloride Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Aminolevulinic Acid Hydrochloride + ER819762 DCHNT1L Aminolevulinic Acid Hydrochloride Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + ER819762 DCG1H8Y Amonafide Adenocarcinoma (Cell Line: OVCAR3) [3]
Amonafide + ER819762 DCJ3FHF Amonafide Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + ER819762 DCJDF75 Anastrozole Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + ER819762 DC8VAV9 Anastrozole Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + ER819762 DCUB61R Anastrozole Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + ER819762 DC90OOZ Anastrozole Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + ER819762 DCVHZ1T Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + ER819762 DCQKV2N Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + ER819762 DCOA0S0 Anastrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + ER819762 DCQUGZE Anastrozole Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + ER819762 DC4N68Y Anastrozole Astrocytoma (Cell Line: U251) [3]
Anastrozole + ER819762 DCR8CX4 Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + ER819762 DCSWWTU Anastrozole Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + ER819762 DC4GOQ4 Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + ER819762 DC6DNWM Anastrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + ER819762 DCI8B6Z Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + ER819762 DCIX5UB Anastrozole Glioma (Cell Line: SF-268) [3]
Anastrozole + ER819762 DC870JH Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + ER819762 DC9ELII Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + ER819762 DC9FC9C Anastrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + ER819762 DCZPCKS Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + ER819762 DC9UTZ7 Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + ER819762 DCWILOG Anastrozole Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + ER819762 DCQW4AN Anastrozole Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + ER819762 DC9C17K Anastrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + ER819762 DCKUALD Anastrozole Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + ER819762 DCDGR3U Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + ER819762 DCP65TF Anastrozole Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + ER819762 DCDSU89 Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + ER819762 DCIP2HI Anastrozole Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + ER819762 DC1ID42 Anastrozole Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + ER819762 DCK1RKY Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Anastrozole + ER819762 DCF8X2J Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [4]
Anastrozole + ER819762 DCRTR6D Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Anastrozole + ER819762 DCU6OLM Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [4]
Arfolitixorin + ER819762 DCVZP2M Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Arfolitixorin + ER819762 DCILTIC Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Arfolitixorin + ER819762 DCOKBT5 Arfolitixorin Melanoma (Cell Line: UACC-257) [2]
Azacitidine + ER819762 DCPR94C Azacitidine Adenocarcinoma (Cell Line: DU-145) [3]
Azacitidine + ER819762 DCJLJKU Azacitidine Adenocarcinoma (Cell Line: OVCAR3) [3]
Azacitidine + ER819762 DCH89YW Azacitidine Adenocarcinoma (Cell Line: A549) [3]
Azacitidine + ER819762 DCMO6FM Azacitidine Adenocarcinoma (Cell Line: HCC-2998) [3]
Azacitidine + ER819762 DCKFP36 Azacitidine Adenocarcinoma (Cell Line: HCT116) [3]
Azacitidine + ER819762 DCT73CK Azacitidine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Azacitidine + ER819762 DCPA1IT Azacitidine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Azacitidine + ER819762 DCI0BES Azacitidine Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Azacitidine + ER819762 DC9TJK3 Azacitidine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Azacitidine + ER819762 DCTM26T Azacitidine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Azacitidine + ER819762 DCQJ3IK Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Azacitidine + ER819762 DCB0MEU Azacitidine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Azacitidine + ER819762 DCJV4MR Azacitidine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bendamustine hydrochloride + ER819762 DCN133M Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bendamustine hydrochloride + ER819762 DC1RSOU Bendamustine hydrochloride Astrocytoma (Cell Line: U251) [3]
Bendamustine hydrochloride + ER819762 DC4R46M Bendamustine hydrochloride Astrocytoma (Cell Line: SNB-19) [3]
Bendamustine hydrochloride + ER819762 DCUH8YL Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bendamustine hydrochloride + ER819762 DCOUJG7 Bendamustine hydrochloride Renal cell carcinoma (Cell Line: SN12C) [3]
Bendamustine hydrochloride + ER819762 DCEHLPP Bendamustine hydrochloride Renal cell carcinoma (Cell Line: UO-31) [3]
Bendamustine hydrochloride + ER819762 DCD4Z31 Bendamustine hydrochloride Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bendamustine hydrochloride + ER819762 DCVJ3CY Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bendamustine hydrochloride + ER819762 DCZDC18 Bendamustine hydrochloride Adenocarcinoma (Cell Line: DU-145) [2]
Bendamustine hydrochloride + ER819762 DCYTVNO Bendamustine hydrochloride Adenocarcinoma (Cell Line: OVCAR3) [2]
Bendamustine hydrochloride + ER819762 DCOIPV3 Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [2]
Bendamustine hydrochloride + ER819762 DC4X1OX Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [2]
Bendamustine hydrochloride + ER819762 DC9C10M Bendamustine hydrochloride Adenocarcinoma (Cell Line: SW-620) [2]
Bendamustine hydrochloride + ER819762 DCP3B3J Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [2]
Bendamustine hydrochloride + ER819762 DCIZ3VS Bendamustine hydrochloride Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Bendamustine hydrochloride + ER819762 DCT7AA4 Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Bendamustine hydrochloride + ER819762 DCTRK6S Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Bendamustine hydrochloride + ER819762 DCKDSZ9 Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: HOP-62) [2]
Bendamustine hydrochloride + ER819762 DCE2HNU Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Bendamustine hydrochloride + ER819762 DCGEBSR Bendamustine hydrochloride Malignant melanoma (Cell Line: UACC62) [2]
Bendamustine hydrochloride + ER819762 DC5IV2K Bendamustine hydrochloride Melanoma (Cell Line: SK-MEL-2) [2]
Bendamustine hydrochloride + ER819762 DCFYZAL Bendamustine hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Bendamustine hydrochloride + ER819762 DCWI0RX Bendamustine hydrochloride Prostate carcinoma (Cell Line: PC-3) [2]
Bleomycin + ER819762 DCWGF23 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + ER819762 DCK7A43 Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + ER819762 DCXFBWK Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + ER819762 DCQFGH5 Bleomycin Renal cell carcinoma (Cell Line: SN12C) [3]
Bleomycin + ER819762 DCCB8IP Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + ER819762 DCNA72R Bleomycin Adenocarcinoma (Cell Line: DU-145) [2]
Bleomycin + ER819762 DCDNAPK Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [2]
Bleomycin + ER819762 DCNXP97 Bleomycin Adenocarcinoma (Cell Line: A549) [2]
Bleomycin + ER819762 DC3QSPP Bleomycin Adenocarcinoma (Cell Line: HCT116) [2]
Bleomycin + ER819762 DCTD2PP Bleomycin Adenocarcinoma (Cell Line: HCC-2998) [2]
Bleomycin + ER819762 DCAX3R0 Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Bleomycin + ER819762 DC3KHU1 Bleomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Bleomycin + ER819762 DC9GM9Y Bleomycin Prostate carcinoma (Cell Line: PC-3) [2]
Busulfan + ER819762 DCCM2LH Busulfan Clear cell renal cell carcinoma (Cell Line: A498) [3]
Busulfan + ER819762 DC2RLDI Busulfan Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Busulfan + ER819762 DC9PZV0 Busulfan Lung adenocarcinoma (Cell Line: EKVX) [3]
Busulfan + ER819762 DCBJOH9 Busulfan Renal cell carcinoma (Cell Line: UO-31) [3]
Cabazitaxel + ER819762 DC1BA35 Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + ER819762 DCLMFB2 Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Crizotinib + ER819762 DCK0PBD Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cyclophosphamide + ER819762 DCK6QPI Cyclophosphamide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + ER819762 DC55JWU Dacarbazine Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + ER819762 DC0TU4K Dacarbazine Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + ER819762 DC13SG2 Dacarbazine Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + ER819762 DC511QI Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + ER819762 DCSJBGF Dacarbazine Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + ER819762 DCDBIR7 Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + ER819762 DCWXD2Z Dacarbazine Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + ER819762 DCNIGPI Dacarbazine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + ER819762 DCUQIOF Dacarbazine Glioma (Cell Line: SF-295) [3]
Dacarbazine + ER819762 DCHOFNA Dacarbazine Glioma (Cell Line: SF-268) [3]
Dacarbazine + ER819762 DCXUD63 Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Dacarbazine + ER819762 DC76J9W Dacarbazine Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + ER819762 DCU8NGR Dacarbazine Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + ER819762 DCBFT7X Dacarbazine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Dacarbazine + ER819762 DCR5DCZ Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + ER819762 DCDNXHJ Dacarbazine Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + ER819762 DC5YAUZ Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dactinomycin + ER819762 DCYAB7K Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + ER819762 DC45J78 Dactinomycin Adenocarcinoma (Cell Line: A549) [2]
Dactinomycin + ER819762 DCEGXH9 Dactinomycin Adenocarcinoma (Cell Line: HCT116) [2]
Dactinomycin + ER819762 DCWEH9J Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Dactinomycin + ER819762 DCJBK6M Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Dactinomycin + ER819762 DCMFUR9 Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Dactinomycin + ER819762 DCM5ZIC Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Dactinomycin + ER819762 DCZSXEG Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Dasatinib + ER819762 DCKC7YL Dasatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dasatinib + ER819762 DCMV3ZR Dasatinib Amelanotic melanoma (Cell Line: M14) [3]
Dasatinib + ER819762 DCFYM8W Dasatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dasatinib + ER819762 DCHT0N0 Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dasatinib + ER819762 DC08P16 Dasatinib Melanoma (Cell Line: SK-MEL-2) [3]
Dasatinib + ER819762 DCK6O1X Dasatinib Carcinoma (Cell Line: MCF7) [4]
Dexrazoxane + ER819762 DC5D4VM Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dexrazoxane + ER819762 DCPR0IP Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Dexrazoxane + ER819762 DCOJB13 Dexrazoxane Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
DFN-15 + ER819762 DCY25BG DFN-15 Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
DFN-15 + ER819762 DCRU2NJ DFN-15 Melanoma (Cell Line: UACC-257) [2]
Digitoxin + ER819762 DC0F9LB Digitoxin Adenocarcinoma (Cell Line: A549) [3]
Digitoxin + ER819762 DC9FBZ8 Digitoxin Prostate carcinoma (Cell Line: PC-3) [3]
Digitoxin + ER819762 DCLRNYN Digitoxin Renal cell carcinoma (Cell Line: SN12C) [3]
Docetaxel + ER819762 DC3NRGN Docetaxel Adenocarcinoma (Cell Line: NCIH23) [3]
Docetaxel + ER819762 DCHYKEC Docetaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Epirubicin + ER819762 DCBCFMO Epirubicin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Epirubicin + ER819762 DCNDEW8 Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Epirubicin + ER819762 DC3AIIL Epirubicin Melanoma (Cell Line: SK-MEL-2) [2]
Epirubicin + ER819762 DCWVZBZ Epirubicin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
ER819762 + Pentostatin DCQH0WW Pentostatin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ER819762 + Ixabepilone DCMUA15 Ixabepilone Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ER819762 + Panobinostat DCX5LOY Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
ER819762 + Arsenic trioxide DC73CHT Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
ER819762 + Arsenic trioxide DC2YSAY Arsenic trioxide Astrocytoma (Cell Line: U251) [3]
ER819762 + Arsenic trioxide DC3QD26 Arsenic trioxide Glioma (Cell Line: SF-539) [3]
ER819762 + Arsenic trioxide DCAV52W Arsenic trioxide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
ER819762 + Arsenic trioxide DCI21R2 Arsenic trioxide Renal cell carcinoma (Cell Line: UO-31) [3]
ER819762 + Ifosfamide DCL7BJD Ifosfamide Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ER819762 + Marizomib DCLOHFE Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
ER819762 + Cisplatin DCWKEYH Cisplatin Astrocytoma (Cell Line: U251) [3]
ER819762 + Cisplatin DCR0PVN Cisplatin Glioma (Cell Line: SF-268) [3]
ER819762 + Chlorambucil DCHX95W Chlorambucil Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ER819762 + Chlorambucil DC6TKNO Chlorambucil Renal cell carcinoma (Cell Line: SN12C) [3]
ER819762 + Pentostatin DCXA93V Pentostatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ER819762 + Pentostatin DCT0635 Pentostatin Carcinoma (Cell Line: MCF7) [4]
ER819762 + Pentostatin DCDGPU6 Pentostatin Colon carcinoma (Cell Line: KM12) [4]
ER819762 + Ixabepilone DC831RC Ixabepilone Invasive ductal carcinoma (Cell Line: T-47D) [4]
ER819762 + Arsenic trioxide DCJZSR6 Arsenic trioxide Colon adenocarcinoma (Cell Line: COLO 205) [4]
ER819762 + Arsenic trioxide DCNRJ4O Arsenic trioxide Invasive ductal carcinoma (Cell Line: T-47D) [4]
ER819762 + Ifosfamide DC0O34S Ifosfamide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
ER819762 + Pentostatin DCKTEXN Pentostatin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
ER819762 + Pentostatin DCHZM5E Pentostatin Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
ER819762 + Pentostatin DCMEBAB Pentostatin Melanoma (Cell Line: UACC-257) [2]
ER819762 + Pentostatin DCOPRC7 Pentostatin Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
ER819762 + Ixabepilone DCW868A Ixabepilone Adenocarcinoma (Cell Line: DU-145) [2]
ER819762 + Arsenic trioxide DCXMEOW Arsenic trioxide Adenocarcinoma (Cell Line: HCT116) [2]
ER819762 + Arsenic trioxide DCWV6PO Arsenic trioxide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
ER819762 + Arsenic trioxide DC0LEW5 Arsenic trioxide Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
ER819762 + Arsenic trioxide DCCNGVN Arsenic trioxide Lung adenocarcinoma (Cell Line: HOP-62) [2]
ER819762 + Arsenic trioxide DCN5MCH Arsenic trioxide Lung adenocarcinoma (Cell Line: NCI-H522) [2]
ER819762 + Arsenic trioxide DCVA7PJ Arsenic trioxide Melanoma (Cell Line: SK-MEL-2) [2]
ER819762 + Arsenic trioxide DCBC9SK Arsenic trioxide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
ER819762 + Ifosfamide DCQ08T1 Ifosfamide Adenocarcinoma (Cell Line: DU-145) [2]
ER819762 + Ifosfamide DC1R05V Ifosfamide Prostate carcinoma (Cell Line: PC-3) [2]
ER819762 + Bortezomib DCII9H4 Bortezomib Adenocarcinoma (Cell Line: HCC-2998) [2]
ER819762 + Bortezomib DCCQT0W Bortezomib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
ER819762 + Bortezomib DC22G43 Bortezomib Malignant melanoma (Cell Line: LOX IMVI) [2]
ER819762 + Bortezomib DCRDF5J Bortezomib Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
ER819762 + Cisplatin DC2CF5O Cisplatin Adenocarcinoma (Cell Line: OVCAR3) [2]
ER819762 + Cisplatin DCO3EG5 Cisplatin Melanoma (Cell Line: SK-MEL-2) [2]
ER819762 + Chlorambucil DC00IU9 Chlorambucil Melanoma (Cell Line: SK-MEL-2) [2]
Estramustine + ER819762 DCM1UFT Estramustine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Estramustine + ER819762 DCSFDLS Estramustine Glioma (Cell Line: SF-295) [3]
Estramustine + ER819762 DCSUTXN Estramustine Carcinoma (Cell Line: RXF 393) [4]
Estramustine + ER819762 DCGIKGG Estramustine Carcinoma (Cell Line: MCF7) [4]
Estramustine + ER819762 DCMQIZM Estramustine Adenocarcinoma (Cell Line: OVCAR3) [2]
Estramustine + ER819762 DCS96IZ Estramustine Adenocarcinoma (Cell Line: HCC-2998) [2]
Estramustine + ER819762 DCCRKMV Estramustine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Estramustine + ER819762 DCKCGSQ Estramustine Melanoma (Cell Line: MALME-3M) [2]
Fludarabine + ER819762 DCYWB7Q Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Fludarabine + ER819762 DCMXSZH Fludarabine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Fludarabine + ER819762 DC5WQ0W Fludarabine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Fludarabine + ER819762 DC44W46 Fludarabine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Fludarabine + ER819762 DCF8Z4P Fludarabine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Fludarabine + ER819762 DCUVI9V Fludarabine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Fludarabine + ER819762 DCOPDK0 Fludarabine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Fludarabine + ER819762 DC2M7QB Fludarabine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Fludarabine + ER819762 DCWRIAZ Fludarabine Adenocarcinoma (Cell Line: A549) [2]
Fludarabine + ER819762 DC0PPYK Fludarabine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Fludarabine + ER819762 DCLYCMS Fludarabine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Fludarabine + ER819762 DC5P328 Fludarabine Melanoma (Cell Line: MALME-3M) [2]
Fludarabine + ER819762 DC3C79X Fludarabine Prostate carcinoma (Cell Line: PC-3) [2]
FORMESTANE + ER819762 DC12KC9 FORMESTANE Adenocarcinoma (Cell Line: NCIH23) [3]
FORMESTANE + ER819762 DC4F4Q3 FORMESTANE Adenocarcinoma (Cell Line: HCC-2998) [3]
FORMESTANE + ER819762 DCT92E2 FORMESTANE Glioma (Cell Line: SF-539) [3]
FORMESTANE + ER819762 DCXJBJA FORMESTANE Glioma (Cell Line: SF-295) [3]
FORMESTANE + ER819762 DC222CG FORMESTANE Lung adenocarcinoma (Cell Line: EKVX) [3]
FORMESTANE + ER819762 DCXH73N FORMESTANE Plasma cell myeloma (Cell Line: RPMI-8226) [3]
FORMESTANE + ER819762 DC523TP FORMESTANE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Fulvestrant + ER819762 DCNHJI0 Fulvestrant Adenocarcinoma (Cell Line: A549) [3]
Fulvestrant + ER819762 DCV3QR5 Fulvestrant Adenocarcinoma (Cell Line: HCC-2998) [3]
Fulvestrant + ER819762 DCOWXYF Fulvestrant Adenocarcinoma (Cell Line: HCT-15) [3]
Fulvestrant + ER819762 DC4JZGT Fulvestrant Chronic myelogenous leukemia (Cell Line: K-562) [3]
Fulvestrant + ER819762 DCBKZGP Fulvestrant Clear cell renal cell carcinoma (Cell Line: A498) [3]
Fulvestrant + ER819762 DC6FDQC Fulvestrant Melanoma (Cell Line: SK-MEL-2) [3]
Fulvestrant + ER819762 DCYFPZN Fulvestrant Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Fulvestrant + ER819762 DCLD8OR Fulvestrant Prostate carcinoma (Cell Line: PC-3) [3]
Fulvestrant + ER819762 DCMCQO3 Fulvestrant Invasive ductal carcinoma (Cell Line: T-47D) [4]
Gefitinib + ER819762 DCQY2CK Gefitinib Adenocarcinoma (Cell Line: DU-145) [3]
Gefitinib + ER819762 DCCBUFD Gefitinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Gefitinib + ER819762 DCT99AL Gefitinib Adenocarcinoma (Cell Line: A549) [3]
Gefitinib + ER819762 DC24JUN Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Gefitinib + ER819762 DCDQ6R6 Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + ER819762 DC1YKGF Gefitinib Melanoma (Cell Line: MALME-3M) [3]
Hepzato + ER819762 DC3AE0G Hepzato Clear cell renal cell carcinoma (Cell Line: A498) [3]
Hepzato + ER819762 DCJMUDT Hepzato Glioma (Cell Line: SF-295) [3]
Hepzato + ER819762 DC0096A Hepzato Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Hepzato + ER819762 DCSL8O9 Hepzato Colon adenocarcinoma (Cell Line: COLO 205) [4]
Hepzato + ER819762 DCF1DRL Hepzato Adenocarcinoma (Cell Line: HCC-2998) [2]
Hepzato + ER819762 DCR87ML Hepzato Lung adenocarcinoma (Cell Line: HOP-62) [2]
Idarubicin + ER819762 DCPY550 Idarubicin Lung adenocarcinoma (Cell Line: EKVX) [2]
Idarubicin + ER819762 DCEUCPD Idarubicin Malignant melanoma (Cell Line: LOX IMVI) [2]
Imatinib + ER819762 DCL7X3D Imatinib Adenocarcinoma (Cell Line: HCT-15) [3]
Imatinib + ER819762 DCR8IUS Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Imatinib + ER819762 DC6KZ46 Imatinib Glioma (Cell Line: SF-268) [3]
Imatinib + ER819762 DCJQM66 Imatinib Glioma (Cell Line: SF-295) [3]
Imatinib + ER819762 DCUMA1J Imatinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Imatinib + ER819762 DCAW4F7 Imatinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Imatinib + ER819762 DCQTIM8 Imatinib Melanoma (Cell Line: UACC-257) [3]
Indazole derivative 5 + ER819762 DC9JDHO Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Indazole derivative 5 + ER819762 DCQN2QN Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Indazole derivative 5 + ER819762 DC8GPUH Indazole derivative 5 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Indazole derivative 5 + ER819762 DCX87SK Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Indazole derivative 5 + ER819762 DCMV28J Indazole derivative 5 Malignant melanoma (Cell Line: LOX IMVI) [2]
Indazole derivative 5 + ER819762 DCU13M7 Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [2]
JNK-IN-8 + ER819762 DCTNMXH JNK-IN-8 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
JNK-IN-8 + ER819762 DCY55RQ JNK-IN-8 Anaplastic large cell lymphoma (Cell Line: SR) [3]
JNK-IN-8 + ER819762 DCD6RVL JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
JNK-IN-8 + ER819762 DC4WZ9Z JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
JNK-IN-8 + ER819762 DCMOKNQ JNK-IN-8 Amelanotic melanoma (Cell Line: M14) [2]
JNK-IN-8 + ER819762 DCIWP8K JNK-IN-8 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Lapatinib + ER819762 DCLOH8Z Lapatinib Adenocarcinoma (Cell Line: HCC-2998) [2]
Lapatinib + ER819762 DC3ESRO Lapatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Lapatinib + ER819762 DC7T8PX Lapatinib Glioma (Cell Line: SF-268) [2]
Lapatinib + ER819762 DC7RJWB Lapatinib Glioma (Cell Line: SF-295) [2]
Lapatinib + ER819762 DCVL6YC Lapatinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Lapatinib + ER819762 DCKHH56 Lapatinib Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Lapatinib + ER819762 DCXS7NZ Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Lenalidomide + ER819762 DCQBYG3 Lenalidomide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Lenalidomide + ER819762 DCKUTYG Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Lenalidomide + ER819762 DCVOYG0 Lenalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Lenalidomide + ER819762 DC1SWJL Lenalidomide Adenocarcinoma (Cell Line: HCC-2998) [2]
Lenalidomide + ER819762 DCFM2GD Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Lenalidomide + ER819762 DCS67DM Lenalidomide Malignant melanoma (Cell Line: UACC62) [2]
Lenalidomide + ER819762 DC02RCR Lenalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Letrozole + ER819762 DC2LTCL Letrozole Adenocarcinoma (Cell Line: OVCAR3) [3]
Letrozole + ER819762 DCQ412O Letrozole Adenocarcinoma (Cell Line: HCT-15) [3]
Letrozole + ER819762 DCD847N Letrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Letrozole + ER819762 DCIBAVO Letrozole Anaplastic large cell lymphoma (Cell Line: SR) [3]
Letrozole + ER819762 DCTYT5C Letrozole Glioma (Cell Line: SF-295) [3]
Letrozole + ER819762 DCBGHHH Letrozole Melanoma (Cell Line: UACC-257) [3]
LIAROZOLE + ER819762 DCKKIB9 LIAROZOLE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
LIAROZOLE + ER819762 DCSO0X5 LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
LIAROZOLE + ER819762 DCLSRPL LIAROZOLE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
LIAROZOLE + ER819762 DCEU140 LIAROZOLE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
LIAROZOLE + ER819762 DC23DSP LIAROZOLE Invasive ductal carcinoma (Cell Line: HS 578T) [4]
LIAROZOLE + ER819762 DC0YIIZ LIAROZOLE Adenocarcinoma (Cell Line: DU-145) [2]
LIAROZOLE + ER819762 DC8RJG8 LIAROZOLE Adenocarcinoma (Cell Line: A549) [2]
LIAROZOLE + ER819762 DCW55VB LIAROZOLE Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
LIAROZOLE + ER819762 DC8Q9TT LIAROZOLE Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Mechlorethamine + ER819762 DCBOWUV Mechlorethamine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Mechlorethamine + ER819762 DCAMP0Y Mechlorethamine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Mechlorethamine + ER819762 DCZYUPP Mechlorethamine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Mechlorethamine + ER819762 DCRZ6CK Mechlorethamine Adenocarcinoma (Cell Line: DU-145) [2]
Mechlorethamine + ER819762 DCXZVAL Mechlorethamine Adenocarcinoma (Cell Line: OVCAR3) [2]
Mechlorethamine + ER819762 DCVLYWG Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Mechlorethamine + ER819762 DCTJK7Q Mechlorethamine Lung adenocarcinoma (Cell Line: EKVX) [2]
Mechlorethamine + ER819762 DCX1OE6 Mechlorethamine Melanoma (Cell Line: SK-MEL-2) [2]
Mepacrine + ER819762 DC3YOSP Mepacrine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Mepacrine + ER819762 DC9Q3VR Mepacrine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Mepacrine + ER819762 DCFY83U Mepacrine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Mercaptopurine + ER819762 DCJEHB7 Mercaptopurine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Mercaptopurine + ER819762 DCODJN4 Mercaptopurine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mercaptopurine + ER819762 DC0BC0V Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Mercaptopurine + ER819762 DCWCADL Mercaptopurine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Mercaptopurine + ER819762 DCD3CP3 Mercaptopurine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Mercaptopurine + ER819762 DCZ1FYY Mercaptopurine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Mercaptopurine + ER819762 DC38UUK Mercaptopurine Adenocarcinoma (Cell Line: A549) [2]
Mercaptopurine + ER819762 DCD00RK Mercaptopurine Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Mercaptopurine + ER819762 DC1DVOQ Mercaptopurine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Methotrexate + ER819762 DCPUIIV Methotrexate Astrocytoma (Cell Line: SNB-19) [3]
Methotrexate + ER819762 DC91J6T Methotrexate Chronic myelogenous leukemia (Cell Line: K-562) [3]
Methotrexate + ER819762 DCSRRDC Methotrexate Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Mitomycin + ER819762 DC1ZN2K Mitomycin Astrocytoma (Cell Line: U251) [3]
Mitomycin + ER819762 DC80WV6 Mitomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Mitomycin + ER819762 DCIVUPO Mitomycin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Mitomycin + ER819762 DC3S55C Mitomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Mitomycin + ER819762 DC5KOVS Mitomycin Glioma (Cell Line: SF-539) [3]
Mitomycin + ER819762 DCYG77E Mitomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Mitomycin + ER819762 DC59EHQ Mitomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Mitomycin + ER819762 DCOWEUZ Mitomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Mitomycin + ER819762 DCBIHKE Mitomycin Colon carcinoma (Cell Line: KM12) [4]
Mitomycin + ER819762 DCYS70R Mitomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Mitomycin + ER819762 DC18QUL Mitomycin Adenocarcinoma (Cell Line: OVCAR3) [2]
Mitomycin + ER819762 DCQUD0M Mitomycin Adenocarcinoma (Cell Line: HT29) [2]
Mitomycin + ER819762 DC13B16 Mitomycin Adenocarcinoma (Cell Line: HCT-15) [2]
Mitomycin + ER819762 DCE8LFJ Mitomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Mitomycin + ER819762 DCW866Y Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Mitomycin + ER819762 DCJE4G4 Mitomycin Malignant melanoma (Cell Line: UACC62) [2]
Mitomycin + ER819762 DCPXNDZ Mitomycin Melanoma (Cell Line: SK-MEL-2) [2]
Mitomycin + ER819762 DC95I8M Mitomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Nilotinib + ER819762 DCBJAHF Nilotinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Nilotinib + ER819762 DCJCNJ6 Nilotinib Glioma (Cell Line: SF-295) [3]
Nilotinib + ER819762 DCYA9FB Nilotinib Glioma (Cell Line: SF-268) [3]
Nilotinib + ER819762 DC6MCJ7 Nilotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Nilotinib + ER819762 DCGITK8 Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Nilotinib + ER819762 DC6ASMW Nilotinib Amelanotic melanoma (Cell Line: M14) [2]
Nilotinib + ER819762 DCDGZUF Nilotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Picoplatin + ER819762 DC01GS5 Picoplatin Glioma (Cell Line: SF-268) [3]
Picoplatin + ER819762 DCT728J Picoplatin Adenocarcinoma (Cell Line: OVCAR3) [2]
Picoplatin + ER819762 DC0DRA3 Picoplatin Adenocarcinoma (Cell Line: NCIH23) [2]
Picoplatin + ER819762 DC6UT62 Picoplatin Adenocarcinoma (Cell Line: HCT-15) [2]
Picoplatin + ER819762 DCPTV8N Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Picoplatin + ER819762 DCKU36B Picoplatin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Picoplatin + ER819762 DCPYCTU Picoplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Picoplatin + ER819762 DCIKLYZ Picoplatin Prostate carcinoma (Cell Line: PC-3) [2]
Plicamycin + ER819762 DCTPEU1 Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Plicamycin + ER819762 DCBR7Q1 Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Plicamycin + ER819762 DCC0EA9 Plicamycin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Plicamycin + ER819762 DC4RBVG Plicamycin Glioma (Cell Line: SF-295) [3]
Plicamycin + ER819762 DCIC01Q Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Plicamycin + ER819762 DCMQNUW Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Plicamycin + ER819762 DCCVGXZ Plicamycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Plicamycin + ER819762 DCEUW9P Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Plicamycin + ER819762 DCE1HF6 Plicamycin Adenocarcinoma (Cell Line: HCT-15) [2]
Plicamycin + ER819762 DCLJXU3 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Plicamycin + ER819762 DCQLR7E Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Plicamycin + ER819762 DCCV2TV Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [2]
Plicamycin + ER819762 DCWYBJH Plicamycin Melanoma (Cell Line: MALME-3M) [2]
PMID28460551-Compound-2 + ER819762 DCCYEXH PMID28460551-Compound-2 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
PMID28460551-Compound-2 + ER819762 DCGCDDK PMID28460551-Compound-2 Glioma (Cell Line: SF-268) [3]
PMID28460551-Compound-2 + ER819762 DCSVBQG PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: COLO 205) [4]
PMID28460551-Compound-2 + ER819762 DCC3J90 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCT116) [2]
PMID28460551-Compound-2 + ER819762 DCHW1ZE PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [2]
PMID28460551-Compound-2 + ER819762 DCIYQVI PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [2]
PMID28460551-Compound-2 + ER819762 DCQ68UX PMID28460551-Compound-2 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
PMID28870136-Compound-43 + ER819762 DCGZO86 PMID28870136-Compound-43 Astrocytoma (Cell Line: U251) [3]
PMID28870136-Compound-43 + ER819762 DCM80SP PMID28870136-Compound-43 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
PMID28870136-Compound-43 + ER819762 DCHUB53 PMID28870136-Compound-43 Glioma (Cell Line: SF-295) [3]
PMID28870136-Compound-43 + ER819762 DCGHSZK PMID28870136-Compound-43 Malignant melanoma (Cell Line: UACC62) [2]
Pomalidomide + ER819762 DC1MKXX Pomalidomide Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Pomalidomide + ER819762 DC2PY55 Pomalidomide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Pralatrexate + ER819762 DCTF9VG Pralatrexate Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Raloxifene + ER819762 DC2VLTK Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Raloxifene + ER819762 DCPN695 Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Raloxifene + ER819762 DC8I3LY Raloxifene Glioma (Cell Line: SF-295) [3]
Raloxifene + ER819762 DCSWECQ Raloxifene Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Raloxifene + ER819762 DCAUHFQ Raloxifene Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Raloxifene + ER819762 DCPQLY8 Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Raloxifene + ER819762 DC8B5WN Raloxifene Adenocarcinoma (Cell Line: DU-145) [2]
Raloxifene + ER819762 DCDPQZ9 Raloxifene Adenocarcinoma (Cell Line: A549) [2]
Raloxifene + ER819762 DCEIQ1U Raloxifene Adenocarcinoma (Cell Line: HCC-2998) [2]
Raloxifene + ER819762 DCDM6KU Raloxifene Adenocarcinoma (Cell Line: SW-620) [2]
Raloxifene + ER819762 DC6PWO1 Raloxifene Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Raloxifene + ER819762 DCW8OF9 Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Raloxifene + ER819762 DCPX0Q8 Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Raloxifene + ER819762 DCBVQCK Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Raloxifene + ER819762 DC5X0S0 Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [2]
Raloxifene + ER819762 DCC30EM Raloxifene Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Raloxifene + ER819762 DCZ9LEM Raloxifene Prostate carcinoma (Cell Line: PC-3) [2]
Ruxolitinib + ER819762 DCNL94R Ruxolitinib Adenocarcinoma (Cell Line: OVCAR3) [2]
Ruxolitinib + ER819762 DCDZH5S Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Ruxolitinib + ER819762 DCIWKRJ Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [2]
SCH 727965 + ER819762 DCZUPN5 SCH 727965 Astrocytoma (Cell Line: U251) [3]
SCH 727965 + ER819762 DCRS8Z5 SCH 727965 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
SCH 727965 + ER819762 DC0OQ7U SCH 727965 Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Sirolimus + ER819762 DC0POUY Sirolimus Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Sorafenib + ER819762 DCQGG2W Sorafenib Adenocarcinoma (Cell Line: HT29) [3]
Sorafenib + ER819762 DCTN08E Sorafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Sorafenib + ER819762 DCYJ8RM Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Sorafenib + ER819762 DC97YW9 Sorafenib Glioma (Cell Line: SF-295) [3]
Sorafenib + ER819762 DCEX2CV Sorafenib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Sorafenib + ER819762 DCB3ZOS Sorafenib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Sorafenib + ER819762 DCYWLLK Sorafenib Carcinoma (Cell Line: RXF 393) [4]
Sorafenib + ER819762 DCSKKAY Sorafenib Carcinoma (Cell Line: MCF7) [4]
Sorafenib + ER819762 DCD5D0T Sorafenib Colon carcinoma (Cell Line: KM12) [4]
SY-1425 + ER819762 DCT8LGX SY-1425 Adenocarcinoma (Cell Line: NCIH23) [2]
SY-1425 + ER819762 DCHQY7Z SY-1425 Adenocarcinoma (Cell Line: A549) [2]
SY-1425 + ER819762 DCXGV22 SY-1425 Amelanotic melanoma (Cell Line: M14) [2]
Taxol + ER819762 DCDH3PT Taxol Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Taxol + ER819762 DCS3FJZ Taxol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Taxol + ER819762 DCF24Y5 Taxol Chronic myelogenous leukemia (Cell Line: K-562) [3]
Taxol + ER819762 DCLZ4SC Taxol Invasive ductal carcinoma (Cell Line: T-47D) [4]
Taxol + ER819762 DC0WOTD Taxol Adenocarcinoma (Cell Line: OVCAR3) [2]
Taxol + ER819762 DC3QI2D Taxol Adenocarcinoma (Cell Line: A549) [2]
Taxol + ER819762 DCYGAN9 Taxol Adenocarcinoma (Cell Line: HCT116) [2]
Taxol + ER819762 DCHRBXU Taxol Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Taxol + ER819762 DCSKCEG Taxol Lung adenocarcinoma (Cell Line: HOP-62) [2]
Taxol + ER819762 DC7N4W0 Taxol Malignant melanoma (Cell Line: LOX IMVI) [2]
Taxol + ER819762 DCYVHUL Taxol Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Taxol + ER819762 DCROJ5R Taxol Prostate carcinoma (Cell Line: PC-3) [2]
TEM + ER819762 DCY88JM TEM Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + ER819762 DC7WWH5 TEM Anaplastic large cell lymphoma (Cell Line: SR) [3]
TEM + ER819762 DCMCID3 TEM Glioma (Cell Line: SF-295) [3]
TEM + ER819762 DCO2IZ5 TEM Papillary renal cell carcinoma (Cell Line: ACHN) [3]
TEM + ER819762 DCZ695P TEM Carcinoma (Cell Line: RXF 393) [4]
TEM + ER819762 DC6QEMY TEM Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + ER819762 DCU0X00 TEM Adenocarcinoma (Cell Line: HCC-2998) [2]
TEM + ER819762 DCU9SGC TEM Lung adenocarcinoma (Cell Line: EKVX) [2]
Terameprocol + ER819762 DCHG4CL Terameprocol Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Terameprocol + ER819762 DCOL785 Terameprocol Adenocarcinoma (Cell Line: HCT116) [2]
Terameprocol + ER819762 DCA9JFT Terameprocol Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Terameprocol + ER819762 DCX5L99 Terameprocol High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Terameprocol + ER819762 DCHDIDP Terameprocol Melanoma (Cell Line: MALME-3M) [2]
Terameprocol + ER819762 DCFH9LK Terameprocol Melanoma (Cell Line: UACC-257) [2]
Terameprocol + ER819762 DCHOTXW Terameprocol Prostate carcinoma (Cell Line: PC-3) [2]
Thioguanine + ER819762 DCXA46J Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Thioguanine + ER819762 DCARX4O Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Thioguanine + ER819762 DCSXKS9 Thioguanine Astrocytoma (Cell Line: U251) [3]
Thioguanine + ER819762 DC98MLH Thioguanine Astrocytoma (Cell Line: SNB-19) [3]
Thioguanine + ER819762 DCRZS5G Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Thioguanine + ER819762 DCP72SB Thioguanine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Thioguanine + ER819762 DCB6SC8 Thioguanine Glioblastoma (Cell Line: SNB-75) [3]
Thioguanine + ER819762 DCR4444 Thioguanine Glioma (Cell Line: SF-539) [3]
Thioguanine + ER819762 DC9IUI4 Thioguanine Glioma (Cell Line: SF-295) [3]
Thioguanine + ER819762 DCQE367 Thioguanine Renal cell carcinoma (Cell Line: SN12C) [3]
Thioguanine + ER819762 DCSARWU Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Thioguanine + ER819762 DCDCZTR Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Thioguanine + ER819762 DCYAVA8 Thioguanine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Thioguanine + ER819762 DCKP76Q Thioguanine Adenocarcinoma (Cell Line: DU-145) [2]
Thioguanine + ER819762 DCFU2M6 Thioguanine Adenocarcinoma (Cell Line: A549) [2]
Thioguanine + ER819762 DCF6FN2 Thioguanine Adenocarcinoma (Cell Line: HT29) [2]
Thioguanine + ER819762 DCHNMKL Thioguanine Adenocarcinoma (Cell Line: HCT116) [2]
Thioguanine + ER819762 DCGS3J6 Thioguanine Adenocarcinoma (Cell Line: HCC-2998) [2]
Thioguanine + ER819762 DCBFQ9G Thioguanine Adenocarcinoma (Cell Line: HCT-15) [2]
Thioguanine + ER819762 DCJZ45J Thioguanine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Topotecan + ER819762 DCEOX6C Topotecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Topotecan + ER819762 DCH2QDH Topotecan Carcinoma (Cell Line: RXF 393) [4]
Topotecan + ER819762 DC7QZZY Topotecan Carcinoma (Cell Line: MCF7) [4]
Topotecan + ER819762 DCULSLI Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Topotecan + ER819762 DCKR9O8 Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Topotecan + ER819762 DCFWVSQ Topotecan Astrocytoma (Cell Line: SNB-19) [2]
Topotecan + ER819762 DCRWD1J Topotecan Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Topotecan + ER819762 DCIJT1D Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Topotecan + ER819762 DCRZCFO Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Topotecan + ER819762 DCRP14I Topotecan Glioma (Cell Line: SF-268) [2]
Topotecan + ER819762 DC9XXVI Topotecan Lung adenocarcinoma (Cell Line: EKVX) [2]
Topotecan + ER819762 DCGKBMX Topotecan Melanoma (Cell Line: UACC-257) [2]
Topotecan + ER819762 DCL417N Topotecan Melanoma (Cell Line: MALME-3M) [2]
Topotecan + ER819762 DCBGKWO Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Topotecan + ER819762 DCGFT0L Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Topotecan + ER819762 DCMCFY4 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Topotecan + ER819762 DC4X5YX Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Topotecan + ER819762 DCZWT21 Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Topotecan + ER819762 DCKE4C0 Topotecan Prostate carcinoma (Cell Line: PC-3) [2]
Triapine + ER819762 DCKC356 Triapine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Triapine + ER819762 DCEU82O Triapine Glioma (Cell Line: SF-268) [2]
Triapine + ER819762 DC853SU Triapine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Triapine + ER819762 DC89WYJ Triapine Melanoma (Cell Line: UACC-257) [2]
Trifluridine + ER819762 DCNZSLT Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + ER819762 DCSL234 Trifluridine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Trifluridine + ER819762 DCV5LYB Trifluridine Adenocarcinoma (Cell Line: DU-145) [2]
Trifluridine + ER819762 DCB86EY Trifluridine Adenocarcinoma (Cell Line: NCIH23) [2]
Trifluridine + ER819762 DCV9ELQ Trifluridine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Valrubicin + ER819762 DCXICHQ Valrubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Valrubicin + ER819762 DCGLG7V Valrubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Valrubicin + ER819762 DC5K2QA Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Valrubicin + ER819762 DCNAYAP Valrubicin Lung adenocarcinoma (Cell Line: EKVX) [2]
Valrubicin + ER819762 DCCCEQY Valrubicin Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Vandetanib + ER819762 DCR2DP5 Vandetanib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vandetanib + ER819762 DCTS8CY Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vemurafenib + ER819762 DCHOE5H Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vemurafenib + ER819762 DCAES0Z Vemurafenib Adenocarcinoma (Cell Line: HCT-15) [2]
Vemurafenib + ER819762 DCHWMU1 Vemurafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Vemurafenib + ER819762 DCSSP5N Vemurafenib Prostate carcinoma (Cell Line: PC-3) [2]
Vincristine + ER819762 DC94QAO Vincristine Adenocarcinoma (Cell Line: A549) [3]
Vincristine + ER819762 DC906PJ Vincristine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + ER819762 DCEAJHN Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Vinflunine + ER819762 DCEPR6L Vinflunine Adenocarcinoma (Cell Line: A549) [2]
Vinflunine + ER819762 DCSEAPJ Vinflunine Adenocarcinoma (Cell Line: HCT-15) [2]
Vinflunine + ER819762 DCYZIUR Vinflunine Adenocarcinoma (Cell Line: HCT116) [2]
Vinflunine + ER819762 DC7L9R0 Vinflunine Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Vinflunine + ER819762 DCNHLIP Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Vinflunine + ER819762 DCDCBI9 Vinflunine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Vismodegib + ER819762 DC7QMH3 Vismodegib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vismodegib + ER819762 DC2IU0X Vismodegib Adenocarcinoma (Cell Line: OVCAR3) [2]
Vismodegib + ER819762 DC7G1L2 Vismodegib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Vismodegib + ER819762 DCJZ229 Vismodegib Glioma (Cell Line: SF-268) [2]
Vismodegib + ER819762 DC9P1G5 Vismodegib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 516 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4040).
2 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.